过敏治疗市场规模、份额、成长分析（按类型、按治疗方法、按给药途径、按分销管道、按地区）- 行业预测，2025 年至 2032 年

2023 年全球过敏治疗市场规模价值 225 亿美元，预计将从 2024 年的 241 亿美元成长到 2032 年的 417.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.1%。

全球过敏治疗市场正经历强劲成长，这得益于过敏盛行率的上升、人们意识的增强以及政府和非政府组织为推广适当治疗所采取的支持性倡议。免疫疗法的技术进步和个人化医疗的兴起进一步推动了市场的发展。此外，非处方药 (OTC) 需求的不断增长、医疗保健支出的不断扩大、老年人口的增长以及气喘患者的激增是主要的成长动力。尤其是舌下免疫疗法 (SCIT) 领域，由于其增强免疫力和全身缓解症状的作用，正受到越来越多的关注，《过敏与临床免疫学杂誌》2024 年的一项研究强调了其在治疗过敏性鼻炎方面的作用。然而，先进治疗方法的高昂费用和缺乏保险覆盖是低收入地区应用该疗法的主要障碍。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管分析

过敏治疗市场规模（按类型及复合年增长率） (2025-2032)

• 市场概览
• 眼睛过敏
• 食物过敏
• 皮肤过敏
• 气喘
• 鼻炎
• 其他的

过敏治疗市场规模（依治疗方法划分）及复合年增长率（2025-2032）

• 市场概览
• 抗过敏药物
• 免疫疗法

过敏治疗市场规模（按给药途径和复合年增长率） (2025-2032)

• 市场概览
• 口服
• 吸入
• 鼻内
• 其他的

过敏治疗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 专科诊所
• 居家护理
• 其他的

过敏治疗市场规模（依通路划分）及复合年增长率（2025-2032）

• 市场概览
• 医院药房
• 零售药局
• 网路药局
• 其他的

过敏治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Johnson & Johnson
• Sanofi SA
• GlaxoSmithKline PLC
• F. Hoffmann-La Roche Ltd.（Genentech Inc.）
• Leti Pharma
• LK-Abello AS
• AbbVie Inc.
• Allergy Therapeutics
• Bausch Health Companies Inc.
• Alembic Pharmaceuticals Limited
• Nicox SA
• Novartis International AG
• Teva Pharmaceutical Industries

结论和建议

Global Allergy Treatment Market size was valued at USD 22.5 billion in 2023 and is poised to grow from USD 24.1 billion in 2024 to USD 41.71 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The Global Allergy Treatment Market is experiencing robust growth, fueled by rising allergy prevalence, growing awareness, and supportive initiatives from governments and NGOs aimed at promoting proper treatment. Technological advancements in immunotherapy and the rise of personalized medicine are further boosting the market. Additionally, increasing demand for over-the-counter (OTC) medications, expanding healthcare expenditure, a growing elderly population, and the surge in asthma cases are key growth drivers. Notably, the sublingual immunotherapy (SCIT) segment is gaining traction due to its immune-boosting benefits and systemic relief, with a 2024 study in the Journal of Allergy and Clinical Immunology emphasizing its impact in treating allergic rhinitis. However, high costs of advanced therapies and lack of insurance coverage pose significant barriers in low-income regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Treatment Market Segments Analysis

Global Allergy Treatment Market is segmented by Type, Treatment, Route of Administration, End-Users, Distribution Channel and region. Based on Type, the market is segmented into Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis and Others. Based on Treatment, the market is segmented into Anti-Allergy Drugs and Immunotherapy. Based on Route of Administration, the market is segmented into Oral, Inhalation, Intranasal and Others. Based on End-Users, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Treatment Market

The Global Allergy Treatment market is experiencing substantial growth driven by the increasing prevalence of allergic conditions such as food allergies, atopic dermatitis, allergic rhinitis, and asthma. This surge in demand can be linked to various factors, including dietary changes, climate change, environmental pollution, and urbanization, which are collectively enhancing immune hypersensitivity. Additionally, the introduction of advanced drug formulations that specifically target allergic responses and address long-term management needs further propels market expansion. Notably, the 2024 report from the Centers for Disease Control and Prevention (CDC) highlighted that over 25 million Americans suffer from asthma and roughly 1 in 13 children face food allergies, intensifying the need for effective allergy treatment medications and devices, particularly corticosteroids, leukotriene inhibitors, and antihistamines.

Restraints in the Global Allergy Treatment Market

The Global Allergy Treatment market faces significant restraints due to the high costs associated with targeted therapies, particularly allergen immunotherapies and monoclonal antibodies, which hinder their uptake in middle- and low-income countries. While these treatments demonstrate enhanced clinical efficacy, the ongoing affordability gap restricts access, especially in areas with inadequate insurance coverage. This financial barrier negatively affects market penetration and patient adherence to allergy treatments, ultimately impeding consistent growth across the global landscape. As a result, the disparity in accessibility given economic constraints remains a critical challenge that the allergy treatment market must address to ensure widespread adoption.

Market Trends of the Global Allergy Treatment Market

The Global Allergy Treatment market is experiencing a notable shift as Sublingual Immunotherapy (SLIT) emerges as a preferred choice over traditional injectable therapies. In 2024, there has been a marked increase in the adoption of SLIT, particularly among pediatric and geriatric populations who favor its oral, pain-free administration. This trend is particularly evident in countries like France and South Korea, where SLIT's ease of use and reduced need for clinical supervision have spurred rapid market growth. As patients increasingly prioritize convenience and comfort in their treatment options, SLIT is poised to reshape the allergy management landscape globally, driving further innovations in therapeutic delivery methods.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis

Global Allergy Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Eye Allergy
• Food Allergy
• Skin Allergy
• Asthma
• Rhinitis
• Others

Global Allergy Treatment Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Anti-Allergy Drugs
• Immunotherapy

Global Allergy Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Inhalation
• Intranasal
• Others

Global Allergy Treatment Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare
• Others

Global Allergy Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Allergy Treatment Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Genentech Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leti Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LK-Abello AS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergy Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alembic Pharmaceuticals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nicox SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations